Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1569
HER2amp
Basal A
Methotrexate
DHFR
Metabolism
7448.084
uM
inf
0.07814
0.9454 0.9628 4.9913 0.0228
0.6789
2.8225
HCC1569
HER2amp
Basal A
Methylglyoxal
13500.184
uM
556.12310
1000.00000
-0.9238 -0.7264 1.5291 0.5020
0.9688
1.6266
HCC1569
HER2amp
Basal A
Methylglyoxal
13038.184
uM
632.13660
1000.00000
-0.9835 -0.8849 2.2213 0.5533
0.9831
1.1106
HCC1569
HER2amp
Basal A
MG-132
Proteasome
Proteasome
14245.189
uM
0.19295
0.20172
-0.4258 -0.0760 3.1870 0.5750
0.7385
1.4693
HCC1569
HER2amp
Basal A
MG-132
Proteasome
Proteasome
14245.189
uM
0.19295
0.20172
-0.4258 -0.0760 3.1870 0.5750
0.7385
1.4693
HCC1569
HER2amp
Basal A
MG-132
Proteasome
Proteasome
12523.17
uM
0.27647
0.35616
-0.9387 -0.9245 4.1332 0.8145
0.9988
0.8990
HCC1569
HER2amp
Basal A
MG-132
Proteasome
Proteasome
12523.17
uM
0.27647
0.35616
-0.9387 -0.9245 4.1332 0.8145
0.9988
0.8990
HCC1569
HER2amp
Basal A
MG-132
Proteasome
Proteasome
10872.145
uM
0.13031
0.18552
-0.7385 -0.7306 2.5497 0.7881
0.9993
1.6308
HCC1569
HER2amp
Basal A
MG-132
Proteasome
Proteasome
10872.145
uM
0.13031
0.18552
-0.7385 -0.7306 2.5497 0.7881
0.9993
1.6308
HCC1569
HER2amp
Basal A
Pevonedistat
NAE1
NAE1
10872.148
uM
inf
inf
0.9391 0.9391 0.0000 0.1233
0.0002
1.5151
HCC1569
HER2amp
Basal A
Pevonedistat
NAE1
NAE1
12523.135
uM
2.11670
1.33880
0.1582 0.1069 0.5252 0.2653
0.9225
0.8958
HCC1569
HER2amp
Basal A
Nelfinavir
13038.174
uM
inf
7.51560
0.8956 0.8956 4.6086 0.0039
0.6885
1.2027
HCC1569
HER2amp
Basal A
Nilotinib
ABL
nRTK
10872.145
uM
inf
inf
1.0423 1.0423 0.0000 0.0067
0.0000
1.6308
HCC1569
HER2amp
Basal A
Nilotinib
ABL
nRTK
12523.17
uM
inf
inf
0.8636 0.8636 0.0000 0.0444
0.0000
0.8990
HCC1569
HER2amp
Basal A
NSC 663284
CDC25
CDC
10872.152
uM
2.81980
4.65580
-0.9020 -0.9178 2.0785 0.5801
0.9909
1.5916
HCC1569
HER2amp
Basal A
NSC 663284
CDC25
CDC
12523.152
uM
5.08010
6.32050
-0.9908 -0.9907 5.0000 0.4820
0.9979
0.8423
HCC1569
HER2amp
Basal A
NU6102
CDK1/2
CDK
10872.147
uM
22.76790
44.65710
-0.3187 -1.0000 1.6308 0.1847
0.9547
1.6255
HCC1569
HER2amp
Basal A
NU6102
CDK1/2
CDK
12523.147
uM
19.51060
21.16230
-0.2350 -0.2399 4.8221 0.0716
0.9921
0.9214
HCC1569
HER2amp
Basal A
Nutlin 3a
MDM2
MDM2
7448.066
uM
44.07780
112.5220
0.2947 -1.0000 1.1722 0.0909
0.9721
2.7001
HCC1569
HER2amp
Basal A
Nutlin 3a
MDM2
MDM2
7449.066
uM
54.43230
92.63770
0.4258 -0.3987 1.1027 0.0548
0.9813
1.9622
HCC1569
HER2amp
Basal A
Nutlin 3a
MDM2
MDM2
10442.066
uM
34.35180
50.63960
-0.3326 -0.9564 2.7548 0.1175
0.9908
1.6519
HCC1569
HER2amp
Basal A
Nutlin 3a
MDM2
MDM2
7447.066
uM
23.62940
31.38530
-0.1618 -0.4031 2.0830 0.0771
0.9942
1.5813
HCC1569
HER2amp
Basal A
Olomoucine II
CDK1
CDK
10872.147
uM
4.94960
6.61530
-0.1670 -0.2225 1.2690 0.3203
0.9846
1.6255
HCC1569
HER2amp
Basal A
Olomoucine II
CDK1
CDK
12523.147
uM
5.58910
5.56240
0.0025 0.0117 4.9695 0.2276
0.9943
0.9214
HCC1569
HER2amp
Basal A
Omipalisib
PI3K
PI3K
10442.087
uM
0.01937
0.02358
-0.1923 -0.1632 1.4348 0.6440
0.9963
1.5727